Share Twitter LinkedIn Facebook Email C. Ola Landgren, M.D. Chief of the Myeloma Service in the Division of Hematologic Oncology at Memorial Sloan Kettering Cancer Center Discusses How Can A Private Practice Doctor Use MRD at Lymphoma & Myeloma on October 18, 2018.
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read